Industry Voices and Cannabis News | Page 126 of 142 | Cannabiz

GSK agreement ‘validates’ Satipharm strategy as Cann Group pins hopes on positive clinical trial

by Steve Jones April 7, 2022April 29, 2024

The interest from pharmaceutical giant GlaxoSmithKline in marketing and selling Satipharm CBD products has validated Cann […]

‘Our first crop failed, but we learned along the way’

by Steve Jones April 7, 2022April 29, 2024

Specialist firm urges TGA to rethink position on delta-8 THC

by Martin Lane March 31, 2022April 29, 2024

WA patients forced interstate by ‘nonsensical’ THC rules

by Martin Lane March 31, 2022April 29, 2024

Canopy duo back together at Creso but ‘with a new sheriff in town’

by Steve Jones March 24, 2022April 29, 2024

ANTG-Asterion merger hits the rocks but Canadian firm chases fresh Australian deal

by Steve Jones March 17, 2022April 29, 2024

Medicinal cannabis regulations disguise solid progress in New Zealand

by Carmen Doran March 11, 2022April 29, 2024

Bruce Linton: ‘The cool part of cannabis is there’s no Harvard book on it’

by Steve Jones March 10, 2022April 29, 2024

It’s time for the industry to walk the talk when conducting itself

by Peter Crock March 3, 2022April 29, 2024

What NOT to do when advertising medicinal cannabis products

by Dr Teresa Nicoletti March 3, 2022April 29, 2024